Treatment of ocular rosacea with 40 mg doxycycline in a slow release form
Identifieur interne : 005184 ( Main/Exploration ); précédent : 005183; suivant : 005185Treatment of ocular rosacea with 40 mg doxycycline in a slow release form
Auteurs : Ines Pfeffer [Allemagne] ; Claudia Borelli [Allemagne] ; Manfred Zierhut [Allemagne] ; Martin Schaller [Allemagne]Source :
- JDDG: Journal der Deutschen Dermatologischen Gesellschaft [ 1610-0379 ] ; 2011-11.
Abstract
Background: About 30–50 % of rosacea patients have ocular involvement. The symptoms range from a foreign‐body sensation to conjunctivitis or blepharitis and may even include severe corneal ulcerations. Systemic treatment is generally with tetracycline. Side effects can occur with the usual antimicrobial dose. Patients and Methods: In a retrospective study, seven patients were evaluated who had been treated for ocular rosacea with a sub‐antimicrobial dose of doxycycline 40 mg in a slow‐release form (Oraycea®). The responses were evaluated on the basis of clinical findings. Results: Seven patients with an average age of 63 took slow release doxycycline 40 mg every day for at least two months. In five patients, other systemic drugs had already failed. All patients experienced a clear improvement in their ocular rosacea after an average of 2.29 months of treatment. One patient had complete clearance and another had almost complete clearance. None of the patients experienced side effects. Conclusions: A sub‐antimicrobial dose of slow release doxycycline 40 mg daily is an effective long‐term therapy for ocular rosacea. It is not associated with the side effects of long‐term antibiotic therapy or the risk of resistance.
Url:
DOI: 10.1111/j.1610-0387.2011.07723.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 006A00
- to stream Istex, to step Curation: 006A00
- to stream Istex, to step Checkpoint: 000616
- to stream Main, to step Merge: 005223
- to stream Main, to step Curation: 005184
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of ocular rosacea with 40 mg doxycycline in a slow release form</title><author><name sortKey="Pfeffer, Ines" sort="Pfeffer, Ines" uniqKey="Pfeffer I" first="Ines" last="Pfeffer">Ines Pfeffer</name></author><author><name sortKey="Borelli, Claudia" sort="Borelli, Claudia" uniqKey="Borelli C" first="Claudia" last="Borelli">Claudia Borelli</name></author><author><name sortKey="Zierhut, Manfred" sort="Zierhut, Manfred" uniqKey="Zierhut M" first="Manfred" last="Zierhut">Manfred Zierhut</name></author><author><name sortKey="Schaller, Martin" sort="Schaller, Martin" uniqKey="Schaller M" first="Martin" last="Schaller">Martin Schaller</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E22C69BE8905FE785D85736937031E1D7FC1CD28</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1610-0387.2011.07723.x</idno><idno type="url">https://api.istex.fr/document/E22C69BE8905FE785D85736937031E1D7FC1CD28/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">006A00</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006A00</idno><idno type="wicri:Area/Istex/Curation">006A00</idno><idno type="wicri:Area/Istex/Checkpoint">000616</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000616</idno><idno type="wicri:doubleKey">1610-0379:2011:Pfeffer I:treatment:of:ocular</idno><idno type="wicri:Area/Main/Merge">005223</idno><idno type="wicri:Area/Main/Curation">005184</idno><idno type="wicri:Area/Main/Exploration">005184</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Treatment of ocular rosacea with 40 mg doxycycline in a slow release form</title><author><name sortKey="Pfeffer, Ines" sort="Pfeffer, Ines" uniqKey="Pfeffer I" first="Ines" last="Pfeffer">Ines Pfeffer</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Dermatology, Tübingen University Hospital</wicri:regionArea><wicri:noRegion>Tübingen University Hospital</wicri:noRegion><wicri:noRegion>Tübingen University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Borelli, Claudia" sort="Borelli, Claudia" uniqKey="Borelli C" first="Claudia" last="Borelli">Claudia Borelli</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Dermatology, Tübingen University Hospital</wicri:regionArea><wicri:noRegion>Tübingen University Hospital</wicri:noRegion><wicri:noRegion>Tübingen University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Zierhut, Manfred" sort="Zierhut, Manfred" uniqKey="Zierhut M" first="Manfred" last="Zierhut">Manfred Zierhut</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Ophthalmology, Tübingen University Hospital</wicri:regionArea><wicri:noRegion>Tübingen University Hospital</wicri:noRegion><wicri:noRegion>Tübingen University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Schaller, Martin" sort="Schaller, Martin" uniqKey="Schaller M" first="Martin" last="Schaller">Martin Schaller</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Dermatology, Tübingen University Hospital</wicri:regionArea><wicri:noRegion>Tübingen University Hospital</wicri:noRegion><wicri:noRegion>Tübingen University Hospital</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">JDDG: Journal der Deutschen Dermatologischen Gesellschaft</title><title level="j" type="alt">JDDG JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT</title><idno type="ISSN">1610-0379</idno><idno type="eISSN">1610-0387</idno><imprint><biblScope unit="vol">9</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="904">904</biblScope><biblScope unit="page" to="907">907</biblScope><biblScope unit="page-count">4</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2011-11">2011-11</date></imprint><idno type="ISSN">1610-0379</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1610-0379</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: About 30–50 % of rosacea patients have ocular involvement. The symptoms range from a foreign‐body sensation to conjunctivitis or blepharitis and may even include severe corneal ulcerations. Systemic treatment is generally with tetracycline. Side effects can occur with the usual antimicrobial dose. Patients and Methods: In a retrospective study, seven patients were evaluated who had been treated for ocular rosacea with a sub‐antimicrobial dose of doxycycline 40 mg in a slow‐release form (Oraycea®). The responses were evaluated on the basis of clinical findings. Results: Seven patients with an average age of 63 took slow release doxycycline 40 mg every day for at least two months. In five patients, other systemic drugs had already failed. All patients experienced a clear improvement in their ocular rosacea after an average of 2.29 months of treatment. One patient had complete clearance and another had almost complete clearance. None of the patients experienced side effects. Conclusions: A sub‐antimicrobial dose of slow release doxycycline 40 mg daily is an effective long‐term therapy for ocular rosacea. It is not associated with the side effects of long‐term antibiotic therapy or the risk of resistance.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country></list><tree><country name="Allemagne"><noRegion><name sortKey="Pfeffer, Ines" sort="Pfeffer, Ines" uniqKey="Pfeffer I" first="Ines" last="Pfeffer">Ines Pfeffer</name></noRegion><name sortKey="Borelli, Claudia" sort="Borelli, Claudia" uniqKey="Borelli C" first="Claudia" last="Borelli">Claudia Borelli</name><name sortKey="Schaller, Martin" sort="Schaller, Martin" uniqKey="Schaller M" first="Martin" last="Schaller">Martin Schaller</name><name sortKey="Zierhut, Manfred" sort="Zierhut, Manfred" uniqKey="Zierhut M" first="Manfred" last="Zierhut">Manfred Zierhut</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005184 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005184 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:E22C69BE8905FE785D85736937031E1D7FC1CD28
|texte= Treatment of ocular rosacea with 40 mg doxycycline in a slow release form
}}
| This area was generated with Dilib version V0.6.31. |  |